BofA lowered the firm’s price target on Archer Daniels to $90 from $94 and keeps a Neutral rating on the shares. Despite Archer Daniels’ Q3 adjusted EPS slightly topping the firm’s forecast, BofA views the mix “negatively,” the analyst tells investors. While the firm’s EPS estimates are little changed for 2023-25, it has “significantly cut” its Nutrition earnings forecasts and believes the earnings mix shift warrants a downward adjustment to the stock’s valuation, the analyst added in a post-earnings note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ADM:
- Archer Daniels price target lowered to $90 from $100 at BMO Capital
- Archer Daniels expects ‘another strong year in 2024’
- Archer Daniels raises FY23 EPS view ‘to exceed $7.00’ from ‘around $7.00’
- Archer Daniels says ‘on track’ to exceed previous FY23 earnings expectations
- Archer Daniels reports Q3 EPS $1.63, consensus $1.52
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue